ArticleClinical kidney journal2024

Dapagliflozin treatment of patients with chronic kidney disease without diabetes across different albuminuria levels (OPTIMISE-CKD).

Maria K Svensson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.